Skip to main content

Impetigo News

Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi (ozenoxacin) Cream 1%, a Novel Topical Antibiotic for Impetigo

FAIRFIELD, N.J., Dec. 14, 2017 /PRNewswire/ – Medimetriks Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Xepi (ozenoxacin) Cream, 1%, a new chemical...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Dermatological Disorders

Related drug support groups

mupirocin, Bactroban